ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,638Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 232

$656K Total Retail Price of All Prescriptions

Rank: 30 out of 232

444 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 444 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 11,629 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
OMEPRAZOLE 514 415 1 4
WARFARIN SODIUM 456 348 2 8
SIMVASTATIN 449 392 3 1
AMLODIPINE BESYLATE 444 380 4 2
FUROSEMIDE 378 337 5 7
LEVOTHYROXINE SODIUM 350 293 6 3
METOPROLOL TARTRATE 332 305 7 10
METFORMIN HCL 313 281 8 9
CARVEDILOL 260 240 9 21
ALBUTEROL SULFATE 233 177 10 67
HYDROCODONE-ACETAMINOPHEN 232 188 S3 11 5
FAMOTIDINE 231 188 12 30
ISOSORBIDE MONONITRATE ER 227 215 13 52
ATENOLOL 202 193 14 11
NAMENDA 194 171 15 18
IPRATROPIUM BROMIDE 180 130 16 94
BENAZEPRIL HCL 177 152 17 31
DONEPEZIL HCL 174 162 18 13
LISINOPRIL 163 140 19 6
CEPHALEXIN 160 141 20 108
LOSARTAN POTASSIUM 158 148 21 15
PANTOPRAZOLE SODIUM 158 151 21 26
DIOVAN 157 137 23 27
CLOPIDOGREL 156 145 24 34
GABAPENTIN 156 124 24 12
NOVOLIN R 141 113 26 74
DIGOXIN 138 138 27 37
POTASSIUM CHLORIDE 131 108 28 20
ATORVASTATIN CALCIUM 123 99 29 14
LANTUS 122 96 30 36
ENALAPRIL MALEATE 119 107 31 64
TAMSULOSIN HCL 118 118 32 22
PREDNISONE 117 103 33 49
GLIPIZIDE 111 100 34 29
METOPROLOL SUCCINATE 100 89 35 23
PLAVIX 100 100 35 50
GLYBURIDE 96 96 R 37 85
MIRTAZAPINE 94 94 38 28
PHENYTOIN 94 89 38 223
GEMFIBROZIL 94 88 38 104
QUETIAPINE FUMARATE 87 57 41 41
ESCITALOPRAM OXALATE 83 46 42 54
CIPROFLOXACIN HCL 77 69 43 68
TRAMADOL HCL 77 77 43 33
NOVOLIN 70-30 74 66 45 283
CILOSTAZOL 74 72 45 246
PRAVASTATIN SODIUM 71 67 47 32
CLONIDINE HCL 71 63 47 58
ZOLPIDEM TARTRATE 70 51 49 19
LEVETIRACETAM 69 46 50 72
IBUPROFEN 69 58 50 65
GLIMEPIRIDE 68 61 52 75
HYDROCHLOROTHIAZIDE 67 60 53 16
SANTYL 66 41 54 224
LACTULOSE 63 48 55 90
RISPERIDONE 63 52 55 42
ISOSORBIDE DINITRATE 63 63 55 189
CYMBALTA 62 55 58 57
SPIRONOLACTONE 62 47 58 77
ADVAIR DISKUS 61 57 60 44
SUCRALFATE 59 57 61 178
GENERLAC 58 53 62 228
HUMULIN R 57 55 63 152
NEXIUM 57 53 63 45
AZITHROMYCIN 56 49 65 51
INSULIN SYRINGE 56 52 65 127
ALLOPURINOL 55 48 67 39
PHENYTOIN SODIUM EXTENDED 52 35 68 122
RANITIDINE HCL 51 46 69 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.